ID

34385

Description

Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy; ODM derived from: https://clinicaltrials.gov/show/NCT00861172

Link

https://clinicaltrials.gov/show/NCT00861172

Keywords

  1. 1/17/19 1/17/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 17, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Lesions NCT00861172

Eligibility Lesions NCT00861172

  1. StudyEvent: Eligibility
    1. Eligibility Lesions NCT00861172
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age between 18 and 50 years.
Description

ID.1

Data type

boolean

health coverage.
Description

ID.2

Data type

boolean

any form of ms defined by mc donald's criteria (2005).
Description

ID.3

Data type

boolean

patients having shown an enhanced plaque on a less than six month mri examination.
Description

ID.4

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with an immunomodulating therapy like natalizumab (tysabri) and intravenous immunosuppressive therapies. other therapies will not be excluded from this study. for patients treated by systemic corticotherapy, a one-month delay will be necessary before a mri examination.
Description

ID.5

Data type

boolean

cerebral microangiopathy (diabetes, arterial hypertension, vascularitis…)
Description

ID.6

Data type

boolean

patient with classical mri contraindication like pace-maker, cardiac valvulosis, claustrophobia, allergy to contrast agent …
Description

ID.7

Data type

boolean

pregnancy or pregnancy desire.
Description

ID.8

Data type

boolean

patient with a low creatinine clearance <60 ml/mn
Description

ID.9

Data type

boolean

Similar models

Eligibility Lesions NCT00861172

  1. StudyEvent: Eligibility
    1. Eligibility Lesions NCT00861172
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age between 18 and 50 years.
boolean
ID.2
Item
health coverage.
boolean
ID.3
Item
any form of ms defined by mc donald's criteria (2005).
boolean
ID.4
Item
patients having shown an enhanced plaque on a less than six month mri examination.
boolean
Item Group
C0680251 (UMLS CUI)
ID.5
Item
patients with an immunomodulating therapy like natalizumab (tysabri) and intravenous immunosuppressive therapies. other therapies will not be excluded from this study. for patients treated by systemic corticotherapy, a one-month delay will be necessary before a mri examination.
boolean
ID.6
Item
cerebral microangiopathy (diabetes, arterial hypertension, vascularitis…)
boolean
ID.7
Item
patient with classical mri contraindication like pace-maker, cardiac valvulosis, claustrophobia, allergy to contrast agent …
boolean
ID.8
Item
pregnancy or pregnancy desire.
boolean
ID.9
Item
patient with a low creatinine clearance <60 ml/mn
boolean

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial